BioXcel Therapeutics (BTAI) Q2 2026 Earnings

May 15Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.72
-1.99
-1.26
-0.53

Details

Expected EPS
-0.5325
Actual EPS
-0.54
Surprise EPS
-0.01
Surprise Percent
-1.41%

Description

⁨BioXcel Therapeutics⁩ (⁦BTAI⁩) has reported earnings of ⁦-0.54⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts